|
Market Closed -
Nasdaq
16:00:00 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 20.11 USD | +0.80% |
|
-2.05% | -24.71% |
| 09-28 | Neuren Says US Patent Allowance Could Extend Trofinetide Protection to 2041 | MT |
| 09-28 | Acadia Pharmaceuticals Gets US Patent Office Allowance for Trofinetide Dosing Patent | MT |
Stock exchange
Nasdaq
ACAD 20.11 $
+0.80%
63.39M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ACAD | 20.11USD | +0.80% | 63.39M $ | ||
CBOE
| ACAD | 20.10USD | +0.75% | 2.95M $ | |
|
Mexican S.E.
| ACAD * | 368.00MXN | -26.25% | 87.95K $ | |
|
Börse Stuttgart
| DR6 | 17.82EUR | +0.68% | 2.67K € | |
|
Tradegate
| DR6 | 17.92EUR | +1.04% | 358.4 € | |
|
Boerse Muenchen
| DR6 | 17.84EUR | -0.20% | 17.84 € | |
|
Deutsche Boerse AG
| DR6 | 17.66EUR | +0.34% | 0 € |
Quotes 5-day view: Acadia Pharmaceuticals Inc.
Delayed Quote Nasdaq
| 2026-09-29 | 2026-09-30 | 2026-10-01 | 2026-10-02 | 2026-10-05 | |
|---|---|---|---|---|---|
| Last | US$20.22 | US$20.15 | US$19.89 | US$19.95 | US$20.11 |
| Volume | 2,515,050 | 3,134,008 | 2,731,696 | 2,564,592 | 3,152,347 |
| Change | -1.51% | -0.35% | -1.29% | +0.30% | +0.80% |
| Opening | US$20.61 | US$20.28 | US$19.95 | US$20.01 | US$20.05 |
| High | US$20.61 | US$20.70 | US$20.19 | US$20.24 | US$20.45 |
| Low | US$20.06 | US$19.93 | US$19.59 | US$19.88 | US$19.57 |
Performance
| 1 day | +0.80% | ||
| 1 week | -2.05% | ||
| Current month | -0.20% | ||
| 1 month | -28.23% | ||
| 3 months | -22.56% | ||
| 6 months | -9.41% | ||
| Current year | -24.71% | ||
| 1 year | -7.75% | ||
| 3 years | -8.42% | ||
| 5 years | +18.85% | ||
| 10 years | -30.20% |
Volumes
marketsDaily volume
3,152,355
Estimated daily volume
3,152,355
Avg. Volume 20 sessions
2,643,872
Daily volume ratio
1.19
Avg. Volume 20 sessions USD
53,168,265.92
Record volume 1
60,106,050
Record volume 2
50,927,750
Record volume 3
40,012,360
Capital turnover ratio
0.02
Float rotation
0.02
Basic data
Market Cap (USD)
3,437,495,084
Net sales (USD)
1,071,505,000
Number of employees
797
Sales / Employee (USD)
1,344,423
Free-Float
99.67%
Free-Float capitalization (USD)
3,426,158,217
Average Daily Capital Traded
1.55%
Indicators
Moving average 5 days
20.06
Moving average 20 days
24.86
Moving average 50 days
26.95
Moving average 100 days
25.01
Price spread / (MMA5)
-0.23%
Price spread / (MMA20)
+23.63%
Price spread / (MMA50)
+34.01%
Price spread / (MMA100)
+24.38%
STIM
RSI 9 days
9.67
RSI 14 days
16.33
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -2.05% | -7.75% | -8.42% | 3.44B | |
| +4.16% | +3.42% | +49.37% | +94.17% | 74.16B | |
| -0.37% | -3.81% | +19.75% | +78.12% | 57.39B | |
| +1.63% | -1.61% | +3.83% | +36.89% | 47.64B | |
| +0.50% | +2.94% | +344.62% | +722.17% | 44.29B | |
| +3.05% | -1.80% | +28.78% | +34.51% | 42.5B | |
| +1.00% | -1.46% | +5.17% | +111.90% | 40.71B | |
| -0.54% | +2.41% | +9.31% | +58.85% | 30.97B | |
| +3.88% | +7.57% | +37.02% | +31.69% | 28.53B | |
| +0.76% | -1.45% | -7.44% | -11.12% | 24.34B | |
| Average | +1.49% | -0.33% | +48.27% | +114.88% | 39.4B | |
| Weighted average by Cap. | +1.71% | -0.42% | +57.90% | +136.20% |
Historical Quotes: Acadia Pharmaceuticals Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
65c0.wzULccaLDrWdHPCGQAgq_LfBmJlJ1xaYuTobAMOgyZ8.iGZyA_fyZ4LOZcP_EUNFnfGM7fILpFOo_05NVbTOoumCBVlJgOJ939t4uQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 20.11 | 785,301 | 2,396,167 |
| 15:59:59 | 20.10 | 106 | 1,610,866 |
| 15:59:59 | 20.10 | 100 | 1,610,760 |
| 15:59:59 | 20.10 | 200 | 1,610,660 |
| 15:59:59 | 20.10 | 100 | 1,610,460 |
| 15:59:59 | 20.10 | 200 | 1,610,360 |
| 15:59:59 | 20.10 | 100 | 1,610,160 |
| 15:59:59 | 20.10 | 200 | 1,610,060 |
| 15:59:59 | 20.10 | 200 | 1,609,860 |
| 15:59:59 | 20.10 | 100 | 1,609,660 |
Price Extremes
| 1 week | 19.57 |  | 20.7 |
| 1 month | 19.57 | | 28.24 |
| Current year | 19.57 | | 30.96 |
| 1 year | 19.57 | | 30.96 |
| 3 years | 13.4 | | 32.59 |
| 5 years | 12.24 | | 33.99 |
| 10 years | 12.24 | | 58.72 |
Monthly variations
Annual variations
| 2026 | -24.71% | ||
| 2025 | +45.56% | ||
| 2024 | -41.39% | ||
| 2023 | +96.67% | ||
| 2022 | -31.79% | ||
| 2021 | -56.34% | ||
| 2020 | +24.96% | ||
| 2019 | +164.56% | ||
| 2018 | -46.30% | ||
| 2017 | +4.40% | ||
| 2016 | -19.10% | ||
| 2015 | +12.28% | ||
| 2014 | +27.05% | ||
| 2013 | +437.42% | ||
| 2012 | +330.56% | ||
| 2011 | -10.00% | ||
| 2010 | -9.09% | ||
| 2009 | +46.67% | ||
| 2008 | -91.87% | ||
| 2007 | +25.94% | ||
| 2006 | -10.76% | ||
| 2005 | +45.49% | ||
| 2004 | +1.04% |
- Stock Market
- Stocks
- ACAD Stock
- Quotes Acadia Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
